Article thumbnail

Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy

By A. R. Ibrahim, C. Paliompeis, M. Bua, D. Milojkovic, R. Szydlo, J. S. Khorashad, L. Foroni, A. Reid, H. de Lavallade, K. Rezvani, F. Dazzi, J. F. Apperley, J. M. Goldman and D. Marin
Publisher: American Society of Hematology
Year: 2010
DOI identifier: 10.1182/blood-2010-06-291922
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.